UK institutions and system
British Patient Capital Interim Evaluation report
What it examines
Examines British Patient Capital’s rationale, delivery, effects on companies and funds, and economic value for money. The interim evaluation reports additional capital supply and improved access to growth finance, with positive effects on company development.
Why it matters
Provides programme-level evidence about one of BBB’s principal long-term equity investment channels.
Publication date shown by the publisher; the URL retains a 2022 suffix.
Institutions and themes
Catalogue entry reviewed 17 September 2026. The summary describes the publication’s analysis; it does not establish that historical findings remain current.